Growing regulatory pressure and challenge of litigations over adverse or side effects, rapidly changing demographic patterns, drying product pipelines and consistent growth in competition from generic manufacturers are some of the prime challenges faced in the life sciences business. Further growth in cost of drug development, approvals and growing responsibilities and obligations on the regulatory front have driven organizations to adopt outsourcing services for regulatory operations. These activities are proven to result in improved cost efficiencies, while manufacturers becoming more focused on their core competencies. Diversification of several ancillary activities allows organizations to focus in improving core business while the third party vendors deliver optimal services. Some major advantages derived from regulatory affairs outsourcing are increased speed of market approvals, effective maintenance of product success in new and emerging markets, and swift and convenient extension of brand indications and formulations. Regulatory affairs outsourcing is also of high advantage for mid and small size companies that lack expertize in certain departments. This also reduced the work-load on the employees and management while also ensure appropriate timely and prompt regulatory submissions.
"Regulatory writing and publishing to be the major revenue generator, while clinical trial and product registration services to pick pace within the forecast period"
Among the major regulatory affairs outsourcing services, regulatory writing and publishing occupy the largest revenue share in the global market. As the global market is condensing, there is a prominent visibility of distinct regulatory scenarios in different regions. Companies domiciled in Europe and North America often face challenge in terms of regulatory submissions to emerging markets of Asia Pacific, and Middle East & Africa. The regulations worldwide are also changing rapidly due to growing interest to ensure rapid commercialization of products with assured safety profile. Therefore, it has become imperative for manufacturers to provide timely data updating of regulatory submissions and literature. Furthermore, it is anticipated that the market for clinical trials and product registration services shall be witnessing rapid growth during the forecast period. Impending patent expiries, and increasing focus of drug manufacturers on delivering drugs for rare diseases have prompted emergence of pipeline for specialty drugs. With growth in the number of such drug candidates, the demand for clinical trial and product registration services shall be growing in the years to come.
"Asia Pacific to become the global outsourcing hub"
Manufacturers of several blockbuster drugs are domiciled in Europe and North America, where the patents for such drugs are rapidly expiring. In order to enable extension to the product life cycle, several of such manufacturers have increased their efforts in introducing their drugs and medical devices to the emerging markets of Asia Pacific. Companies are harnessing the potential of the emerging economies as an introduction opportunity for their businesses and products in the developed markets. CDMO and regulatory outsourcing activities are being increasingly set up in emerging economies due to cheap labor, improving skills and low service costs.
Historical & Forecast Period
This research report presents the analysis of each considered segment for the period from 2016 to 2026, having 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.
This report also includes company profiles section that gives insights on the company overview, product portfolio, financial information and key developments of major market players. The major players profiled in this report include ICON plc, Quintiles Transnational Corporation, PAREXEL International Corporation, Covance, Inc., Clinilabs, Inc., Charles River Laboratories International, Inc., Accell Clinical Research, LLC, Criterium, Inc., Medpace, Inc., Promedica International, WuXi App Tec, Genpact Ltd, PRA Health Sciences, Inc. and Pharmaceutical Product Development (PPD), LLC.
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Approach Adopted
1.3.4. Top Down Approach
1.3.5. Bottom Up Approach
1.3.6. Phase III – Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global RAOS Market Portraiture
2.2. Global RAOS Market, by Type, 2017 (US$ Mn)
2.3. Global RAOS Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Regulatory Affairs Outsourcing Services (RAOS) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Industry Pros and Cons
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Major Agreements and Strategic Alliances
3.8. Attractive Investment Proposition, by Geography, 2017
3.9. Competitive Analysis: Global RAOS Market, by Key Players, 2017
Chapter 4. Global Regulatory Affairs Outsourcing Services (RAOS) Market, by Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Regulatory Writing & Publishing
4.3. Regulatory Consulting
4.4. Clinical Trial & Product Registration
4.5. Legal Representation
4.6. Other Services
Chapter 5. Global Regulatory Affairs Outsourcing Services (RAOS) Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America RAOS Market, 2016 - 2026 (US$ Mn)
5.2.1. North America RAOS Market, by Type, 2016 - 2026 (US$ Mn)
5.2.2. North America RAOS Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe RAOS Market, 2016 – 2026 (US$ Mn)
5.3.1. Europe RAOS Market, by Type, 2016 - 2026 (US$ Mn)
5.3.2. Europe RAOS Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. France
5.3.2.4. Italy
5.3.2.5. Rest of Europe
5.4. Asia Pacific RAOS Market, 2016 – 2026 (US$ Mn)
5.4.1. Asia Pacific RAOS Market, by Type, 2016 - 2026 (US$ Mn)
5.4.2. Asia Pacific RAOS Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. India
5.4.2.4. Australia
5.4.2.5. Rest of Asia Pacific
5.5. Latin America RAOS Market, 2016 – 2026 (US$ Mn)
5.5.1. Latin America RAOS Market, by Type, 2016 - 2026 (US$ Mn)
5.5.2. Latin America RAOS Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa RAOS Market, 2016 – 2026 (US$ Mn)
5.6.1. Middle East & Africa RAOS Market, by Type, 2016 - 2026 (US$ Mn)
5.6.2. Middle East & Africa RAOS Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. South Africa
5.6.2.3. Rest of Middle East & Africa
Chapter 6. Company Profiles
6.1. ICON plc
6.1.1. Company Overview
6.1.2. Financial Information (Subject to Data Availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Quintiles Transnational Corporation
6.3. PAREXEL International Corporation
6.4. Covance, Inc.
6.5. Clinilabs, Inc.
6.6. Charles River Laboratories International, Inc.
6.7. Accell Clinical Research, LLC
6.8. Criterium, Inc.
6.9. Medpace, Inc.
6.10. Promedica International
6.11. WuXi App Tec
6.12. Genpact Ltd
6.13. PRA Health Sciences, Inc.
6.14. Pharmaceutical Product Development (PPD), LLC
* RAOS - Regulatory Affairs Outsourcing Services
TABLE 1. Global Regulatory Affairs Outsourcing Services (RAOS) Market Portraiture
TABLE 2. Global RAOS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3. Global RAOS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4. North America RAOS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5. North America RAOS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6. Europe RAOS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7. Europe RAOS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8. Asia Pacific RAOS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9. Asia Pacific RAOS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10. Latin America RAOS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 11. Latin America RAOS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12. Middle East and Africa RAOS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13. Middle East and Africa RAOS Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14. ICON plc: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 15. Quintiles Transnational Corporation: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 16. PAREXEL International Corporation: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 17. Covance, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 18. Clinilabs, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 19. Charles River Laboratories International, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 20. Accell Clinical Research, LLC: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 21. Criterium, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 22. Medpace, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 23. Promedica International: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 24. WuXi App Tec: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 25. Genpact Ltd: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 26. PRA Health Sciences, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 27. Pharmaceutical Product Development (PPD), LLC: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
TABLE 28. Patterson Companies, Inc.: Company Snapshot (Company Overview; Financial Information; Product Portfolio; Key Developments)
FIG 1. Regulatory Affairs Outsourcing Services (RAOS) Market: Research Methodology
FIG 2. Market Size Estimation – Top Down & Bottom up Approach
FIG 3. RAOS: Market Segmentation
FIG 4. Global RAOS Market, by Type, 2017 (US$ Mn)
FIG 5. Global RAOS Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global RAOS Market, by Key Players, 2017
FIG 8. Global Regulatory Writing & Publishing Services Market, 2016 - 2026 (US$ Mn)
FIG 9. Global Regulatory Consulting Services Market, 2016 - 2026 (US$ Mn)
FIG 10. Global Clinical Trial & Product Registration Services Market, 2016 - 2026 (US$ Mn)
FIG 11. Global Legal Representation Services Market, 2016 - 2026 (US$ Mn)
FIG 12. Global Other RAOS Market, 2016 - 2026 (US$ Mn)
FIG 13. U.S. RAOS Market, 2016 - 2026 (US$ Mn)
FIG 14. Canada RAOS Market, 2016 - 2026 (US$ Mn)
FIG 15. U.K. RAOS Market, 2016 - 2026 (US$ Mn)
FIG 16. Germany RAOS Market, 2016 - 2026 (US$ Mn)
FIG 17. France RAOS Market, 2016 - 2026 (US$ Mn)
FIG 18. Italy RAOS Market, 2016 - 2026 (US$ Mn)
FIG 19. Rest of Europe RAOS Market, 2016 - 2026 (US$ Mn)
FIG 20. China RAOS Market, 2016 - 2026 (US$ Mn)
FIG 21. Japan RAOS Market, 2016 - 2026 (US$ Mn)
FIG 22. India RAOS Market, 2016 - 2026 (US$ Mn)
FIG 23. Australia RAOS Market, 2016 - 2026 (US$ Mn)
FIG 24. Rest of Asia Pacific RAOS Market, 2016 - 2026 (US$ Mn)
FIG 25. Brazil RAOS Market, 2016 - 2026 (US$ Mn)
FIG 26. Mexico RAOS Market, 2016 - 2026 (US$ Mn)
FIG 27. Rest of Latin America RAOS Market, 2016 - 2026 (US$ Mn)
FIG 28. GCC RAOS Market, 2016 - 2026 (US$ Mn)
FIG 29. South Africa RAOS Market, 2016 - 2026 (US$ Mn)
FIG 30. Rest of Middle East and Africa RAOS Market, 2016 - 2026 (US$ Mn)